CAMILLA PACE: Open Payments
NPI 1740747047 · LAKE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,557 in 70 payments from 18 companies in 2025. Trend: 2023 $1,809 · 2024 $1,984 · 2025 $1,557
Food & beverage: $1,557
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $331 |
| AstraZeneca Pharmaceuticals LP | 8 | $328 |
| Lilly USA, LLC | 8 | $154 |
| Boston Scientific Corporation | 1 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $107 |
| PFIZER INC. | 3 | $70 |
| Sumitomo Pharma America, Inc. | 3 | $66 |
| SK Life Science, Inc. | 2 | $50 |
| Radius Health, Inc. | 2 | $42 |
| Neurelis, Inc. | 2 | $41 |
Products named: FARXIGA, JARDIANCE, WATCHMAN FLX, Wegovy, Ozempic, Rybelsus, MOUNJARO, REXULTI.
Industry payments across FL — which companies pay providers there.
